Cargando…
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
BACKGROUND: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) or ischaemic stroke on the basis of trials showing a 13% reduction in long-term risk of recurrent stroke. However, the risk of major stroke is very high for only the first few days after TIA and minor...
Autores principales: | Rothwell, Peter M, Algra, Ale, Chen, Zhengming, Diener, Hans-Christoph, Norrving, Bo, Mehta, Ziyah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321490/ https://www.ncbi.nlm.nih.gov/pubmed/27209146 http://dx.doi.org/10.1016/S0140-6736(16)30468-8 |
Ejemplares similares
-
Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
por: Hilkens, Nina A, et al.
Publicado: (2020) -
Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study
por: Li, Linxin, et al.
Publicado: (2015) -
Impact of Different Operational Definitions on Mild Cognitive Impairment Rate and MMSE and MoCA Performance in Transient Ischaemic Attack and Stroke
por: Pendlebury, Sarah T., et al.
Publicado: (2013) -
Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study
por: Chinnery, Patrick F, et al.
Publicado: (2010) -
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
por: Tank, Amarjeet, et al.
Publicado: (2023)